electroCore, Inc.
NASDAQ:ECOR
electroCore, Inc.
Other Non-Cash Items
electroCore, Inc.
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
electroCore, Inc.
NASDAQ:ECOR
|
Other Non-Cash Items
$2.4m
|
CAGR 3-Years
15%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Non-Cash Items
$16m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-19%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Non-Cash Items
$676m
|
CAGR 3-Years
47%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
25%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Non-Cash Items
$1.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Non-Cash Items
$604.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
electroCore, Inc.
Glance View
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 52 full-time employees. The company went IPO on 2018-06-22. nVNS is a platform for bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The firm is providing gammaCore device for the treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults. gammaCore permits patients to self-administer doses of nVNS on an as-needed basis for treatment of prevent multiple types of headache pain via the vagus nerve. The gammaCore therapy is also used to treat primary headache, including migraine, cluster headache (CH), hemicrania continua and paroxysmal hemicrania (PH) and coronavirus (COVID-19).
See Also
What is electroCore, Inc.'s Other Non-Cash Items?
Other Non-Cash Items
2.4m
USD
Based on the financial report for Dec 31, 2024, electroCore, Inc.'s Other Non-Cash Items amounts to 2.4m USD.
What is electroCore, Inc.'s Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
0%
Over the last year, the Other Non-Cash Items growth was 1%. The average annual Other Non-Cash Items growth rates for electroCore, Inc. have been 15% over the past three years .
You don't have any saved screeners yet